Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

In Vitro Metabolism of Isoliquiritigenin by Human Liver Microsomes

Jian Guo, Dongting Liu, Dejan Nikolic, Dongwei Zhu, John M. Pezzuto and Richard B. van Breemen
Drug Metabolism and Disposition February 2008, 36 (2) 461-468; DOI: https://doi.org/10.1124/dmd.107.018721
Jian Guo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dongting Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dejan Nikolic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dongwei Zhu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John M. Pezzuto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard B. van Breemen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Isoliquiritigenin (2′,4′,4-trihydroxychalcone), a chalcone found in licorice root and other plants, has shown potent antitumor, antioxidant, and phytoestrogenic activity in vitro. In preparation for in vivo studies, the metabolism of isoliquiritigenin by human liver microsomes was investigated, and seven phase 1 metabolites were identified. In addition to aromatic hydroxylation that occurred on the A or B ring to form 2′,4,4′,5′-tetrahydroxychalcone or butein, respectively, reduction of the carbon-carbon double bond of an α,β-unsaturated ketone and cyclization occurred to form 2′,4,4′-trihydroxydihydrochalcone and (Z/E)-6,4′-dihydroxyaurone. All metabolites were characterized and identified by using liquid chromatography-tandem mass spectrometry with comparison to authenticated compounds. Finally, monoclonal antibody inhibitors of specific human cytochrome P450 (P450) enzymes and recombinant human P450 enzymes were used to identify the enzymes responsible for the formation of the major mono-oxygenated metabolites, and P450 2C19 was found to be a significant enzyme in the formation of butein from isoliquiritigenin, which also has anticancer activity. Cytochromes P450, reactive oxygen species, and peroxidases can all contribute to the formation of (Z/E)-6,4′-dihydroxyaurone in human liver microsomes.

Footnotes

  • This research was supported by Grant P01 CA48112 from the National Cancer Institute.

  • Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.

  • doi:10.1124/dmd.107.018721.

  • ABBREVIATIONS: M1, liquiritigenin; M2, 2′,4,4′,5′-tetrahydroxychalcone; M3, 3′,4,4′-trihydroxyaurone; M4, 2′,3,4,4′-tetrahydroxychalcone; M5, 2′,4,4′-trihydroxydihydrochalcone; M6, (Z)-6,4′-dihydroxyaurone; M7, (E)-6,4′-dihydroxyaurone; LC, liquid chromatography; MS/MS, tandem mass spectrometry; P450, cytochrome P450; HPLC, high-performance liquid chromatography; MS, mass spectrometry; ANOVA, analysis of variance; SOD, superoxide dismutase; CID, collision-induced dissociation.

    • Received September 4, 2007.
    • Accepted November 12, 2007.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (2)
Drug Metabolism and Disposition
Vol. 36, Issue 2
1 Feb 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro Metabolism of Isoliquiritigenin by Human Liver Microsomes
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

In Vitro Metabolism of Isoliquiritigenin by Human Liver Microsomes

Jian Guo, Dongting Liu, Dejan Nikolic, Dongwei Zhu, John M. Pezzuto and Richard B. van Breemen
Drug Metabolism and Disposition February 1, 2008, 36 (2) 461-468; DOI: https://doi.org/10.1124/dmd.107.018721

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

In Vitro Metabolism of Isoliquiritigenin by Human Liver Microsomes

Jian Guo, Dongting Liu, Dejan Nikolic, Dongwei Zhu, John M. Pezzuto and Richard B. van Breemen
Drug Metabolism and Disposition February 1, 2008, 36 (2) 461-468; DOI: https://doi.org/10.1124/dmd.107.018721
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • New Dog P450 3A98 in Gut
  • TMDD Affects PK of IL-10 Fc-Fusion Proteins
  • In Vitro Models to Study P-gp-Mediated Intestinal DDIs
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics